Amphastar Pharmaceuticals AMPH Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's income tax?
- Amphastar Pharmaceuticals (AMPH) reported income tax of $3.63M in Q1 2026.
- How has Amphastar Pharmaceuticals's income tax changed year-over-year?
- Amphastar Pharmaceuticals's income tax decreased by 34.9% year-over-year, from $5.58M to $3.63M.
- What is the long-term trend for Amphastar Pharmaceuticals's income tax?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's income tax has grown at a 5.5% compound annual growth rate (CAGR), from $20.63M to $25.53M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.